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Copyright © 2009 JCBN Summary Nonalcoholic steatohepatitis (NASH) can develop into end-stage disease such as
cryptogenic cirrhosis and hepatocellular carcinoma. Hence, it is important to understand the
pathogenesis of NASH. In general, the “two-hit theory” has prevailed as a pathogenic mecha-
nism of NASH. According to this theory, lipopolysaccharides (LPS) contained in normal portal
blood are the “second hit,” but their role is not completely understood. Based on this theory,
we evaluated the role of LPS in NASH pathogenesis. For the first hit to develop metabolic
abnormalities, a synthetic diet rich in disaccharide (synthetic diet: 12.1 cal% disaccharide)
was fed to Zucker (fa/fa) rats for 12 weeks. For the second hit, 100 µg/kg LPS was injected
intraperitoneally once daily for 2 weeks. Synthetic diet-fed rats treated with LPS showed an
increase in the triglyceride content and higher expression of profibrogenic mRNAs in the liver.
Plasma alanine aminotransferase levels were significantly elevated using this protocol.
Furthermore, histological examination demonstrated that this protocol induced mild hepatic
fibrosis and focal necrosis in the livers of all rats. Synthetic diet-fed Zucker (fa/fa) rats treated
with LPS could be useful for understanding the development of hepatic fibrosis in the two-hit
theory.
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Introduction
Currently, obesity and its associated diseases are among
the most prevalent and challenging conditions confronting
the medical profession. Nonalcoholic fatty liver disease
(NAFLD) is a clinical and pathological term that encom-
passes a disease spectrum ranging from simple triglyceride
accumulation in hepatocytes to hepatic steatosis with
inflammation, fibrosis, and cirrhosis, and is commonly
observed in obese patients [1]. Nonalcoholic steatohepatitis
(NASH) is a type of NAFLD, and is currently the most
frequent cause of chronic liver disease in developed
countries. It can lead to cirrhosis and increased risk of
hepatocellular carcinoma [2–4]. The pathogenesis of NASH
is yet to be clearly defined, but a recent major acceptedThe Role of LPS on NASH
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theory is “two-hit theory” [5, 6]. The first hit refers to factors
that promote hepatic steatosis [7,  8], and the second hit
refers to factors that aggravate hepatic steatosis to steato-
hepatitis [9–11]. Till date, lipopolysaccrides (LPS) have
been proposed to be the second hit [10]. Leptin- or leptin
receptor-deficient animals that are genetically obese are
highly susceptible to low-dose LPS for short-term (30 min,
1, 6, or 24 h) and develop steatohepatitis [8]. In addition,
probiotics diminish NASH in leptin-deficient ob/ob mice,
suggesting a relationship between enteric flora and liver
injury [12, 13]. However, the exact role of LPS in the patho-
genesis of NASH is not completely understood.
In this study, we attempted to evaluate the role of LPS in
NASH development based on the two-hit theory. Since
NASH is often observed in obesity and type 2 diabetes, we
used obese diabetic Zucker (fa/fa) rats. For the first hit, we
employed a synthetic diet rich in disaccharides (synthetic
diet: 12.1 cal% disaccharide) to induce hepatic steatosis
and metabolic abnormalities in rats. Following this, for the
second hit, the rats were treated with LPS, which is reported
to accelerate inflammation via hepatic production of proin-
flammatory cytokines such as tumor necrosis factor (TNF)-
α [13–15]. We evaluated biochemical and morphological
analysis of synthetic diet-fed Zucker (fa/fa) rats treated with
LPS to study the role of LPS in NASH development.
Material and Methods
Animals
Six-week-old male Zucker (fa/fa) and control (fa/−) rats
were purchased from Nippon SLC Co. Ltd. (Shizuoka,
Japan). Rats were housed in plastic cages for 24 weeks on a
12-h light/12-h dark cycle under controlled temperature
(22 ± 1°C) and humidity (50 ± 10%), with ad libitum access
to food and tap water.
Experimental designs
Rats were fed either a regular diet (Funahashi Farm,
Chiba, Japan) or a synthetic diet rich in disaccharides
(sucrose and lactose; synthetic diet; CLEA Japan Inc.,
Tokyo, Japan) for 12 weeks (Table 1). The calories per gram
were identical in the two diets and the only difference
between the two diets was the content of disaccharides. It
has been reported that feeding Zucker (fa/fa) rats with a diet
rich in disaccharides for 1 week or 3 weeks induces hepatic
steatosis with no fibrosis or infiltration of inflammatory
cells [16]. Our dietary contents induced a gradual hepatic
steatosis compared with the diet reported by Novikoff [16].
Rats were divided into three experimental groups: (i) regular
diet-fed rats treated with LPS (n = 3), (ii) synthetic diet-fed
rats treated with LPS (n = 3), and (iii) synthetic diet-fed rats
treated with saline (n = 3). These rats were intraperitoneally
(i.p.) injected with LPS (Sigma Chemical Co., St. Louis,
MO) at 100 μg/kg once daily for 2 weeks. All rats were fed
for 12 weeks and treated with LPS for the last 2 weeks under
the same conditions. After feeding the respective diet for
12 weeks, the rats were fasted overnight, and blood and
liver samples were collected for further experiments. The
12-week feeding and the last 2-week treatment were carried
out three times.
All surgical and experimental procedures were performed
according to the guidelines for the care and use of animals
approved by Osaka Medical College.
Measurement of plasma biochemical parameters
Levels of plasma alanine aminotransferase (ALT), insulin,
glucose, leptin, and concentrations of LPS were measured
by a local laboratory for clinical examinations (SRL Co.
Ltd., Tokyo, Japan).
Measurement of hepatic biochemical parameters
Hepatic tissues were homogenized with a Janke & Kunkel
Polytron homogenizer (ULTRA-TURRAX TP18/1051;
IKA-Labortechnik, Staufeni, Germany) in a buffer (pH 7.4)
containing 20 mM Tris HCl, 1 mM EGTA, 2 mM EDTA,
and a protease inhibitor (2 μg/mL leupeptin cocktail).
Hepatic tissue triglyceride (TG) levels were measured by
SRL Co. Ltd.
Histology
Livers were formalin fixed, paraffin embedded, and
processed for hematoxylin and eosin (H&E) or Azan staining.
Measurement of mRNA levels in the liver
Total RNA was extracted using trizol reagent (QIAGEN,
Tokyo, Japan) according to the manufacturer’s protocol.
cDNAs were synthesized from 1 μg of isolated RNA using a
first-strand cDNA Synthesis Kit for real-time quantitative
polymerase chain reaction (RT-PCR) (AMV)+ (Roche
Diagnostics, Mannheim, Germany). RT-PCR was performed
for quantitative assessment of mRNA using a Lightcycler
(Roche Diagnostics) according to the manufacturer’s
protocol. The sequences of the primers used were:
Transforming growth factor (TGF)-β1 (TGF-F2, 5'-TGCT-
TCAGCTCCACAGAGAA-3'; TGF-R2, 5'-TACTGTGTGT-
CCAGGCTCCA-3'), type 1 collagen α1 (Col-F1, 5'-
GAGAGCATGACCGATGGATT-3'; Col-R1, 5'-TTGAGG-
Table 1. Diet composition
Regular diet (cal%) Synthetic diet (cal%)
Protein 20.7 20.7
Fat 12.5 9.8
Nitric-free extract 66.8 69.5
Disaccharides 0.1 12.1S. Fukunishi et al.
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TTGCCAGTCTGTTG-3'), α-smooth muscle actin (α-SMA)
(SMA-F1, 5'-TGTGCTGGACTCTGGAGATG-3'; SMA-
R1, 5'-TCCAGAGCGACATAGCACAG-3').
Relative levels of target mRNAs were normalized to the
corresponding level of GADPH mRNA (GADPH-F, 5'-
TGAACGGGAAGCTCACTGG-3'; GADPH-R, 5'-TCC-
ACCACCCTGTTGCTGTA-3') in the same cDNA sample
using a standard curve method recommended in the Light-
cycler Software Ver. 3.5 (Roche Diagnostics). PCR reactions
and analyses were performed according to the manufac-
turer’s protocols (Roche Diagnostics) by UNITECH, Co.
Ltd. (Chiba, Japan).
Statistical analysis
Data are mean ± SD. The significance of differences
among values was analyzed by unpaired Student’s t test. A
p value of <0.01 was considered significant.
Results
According to our hypothesis that LPS plays a role in
hepatic fibrosis and in NASH development, we evaluated
the mechanism of progressive hepatic fibrosis on NASH.
Each of the Zucker (fa/fa) rats groups were fed a regular
or synthetic diet for 12 weeks, and treated with LPS or saline
for the last 2 weeks. The three groups were abbreviated
as follows: regular diet with LPS, regular diet-fed Zucker
(fa/fa) rats treated with LPS group (n = 3); synthetic diet
with LPS, synthetic diet-fed Zucker (fa/fa) rats treated
with LPS group (n = 3); synthetic diet with saline, synthetic
diet-fed Zucker (fa/fa) rats treated with saline group (n =3 ) .
Body weight and liver/body weight ratio
Body weight at the end of the experimental period
increased significantly in the synthetic diet with LPS group
compared to the other groups (531 ± 11.5, 584.3 ± 2.1, and
551 ± 3.6 g; in regular diet with LPS, synthetic diet with
LPS, synthetic diet with saline, respectively) (Fig. 1).
Liver/body weight ratio increased significantly in the
synthetic diet with LPS group compared to the other groups
(p<0.01) (Table 2).
Plasma and hepatic biochemical parameters
Synthetic diet with LPS showed significantly higher
levels of plasma glucose and insulin among all groups
(p<0.01) (Table 2).
To examine whether synthetic diet with LPS induced
liver damage and steatosis, we quantified plasma ALT
levels and hepatic TG accumulations. Plasma ALT levels in
the synthetic diet with LPS group were about 2–3 times
significantly higher than those in the other groups (p<0.01)
(Table 2). Hepatic TG levels were compared among the
groups and were found to be about 1.3–2.4 times signifi-
cantly higher in the synthetic diet with LPS group than those
in the other groups (p<0.01) (Table 2).
Zucker (fa/fa) rats, which are homozygous for leptin
receptor mutation, have a deficiency in leptin signaling,
and exhibit hyperphagia, obesity, and type 2 diabetes. We
evaluated plasma leptin levels since it contributes to hepatic
Fig. 1. Development of obesity in Zucker (fa/fa) rats fed a syn-
thetic diet or regular diet. Data are mean ± SD *p<0.01
vs Regular diet with LPS, **p<0.01 vs Synthetic diet
with saline.
Table 2. Plasma, hepatic biochemical parameters, and liver weight/body weight ratios of Zucker (fa/fa) rats fed a regular diet or a syn-
thetic diet, and injected with LPS or saline (i.p.)
Data are mean ± SD. *p<0.01 vs regular diet + LPS. **p<0.01 vs synthetic diet + saline.
Regular diet + LPS Synthetic diet + LPS Synthetic diet + saline
(n =3 ) ( n =3 ) ( n =3 )
Liver/body weight ratio (%) 3.2 ± 0.12 4.3 ± 0.2*,** 3.5 ± 0.1
Glucose (mg/dL) 233.46 ± 4.64 268.08 ± 4.35*,** 239.97 ± 3.2
Insulin (ng/mL) 10.85 ± 0.39 24 ± 1.16*,** 16.76 ± 0.34*
ALT (IU/L) 87.06 ± 3.23** 172.52 ± 31.59*,** 63.26 ± 5.63
Leptin (ng/mL) 108.25 ± 4.47 259.8 ± 6.39*,** 143.38 ± 7.35*
Hepatic TG (mg/dL) 94.53 ± 5.47 227.72 ± 11.36*,** 169.47 ± 3.59*The Role of LPS on NASH
Vol. 45, No. 3, 2009
325
fibrosis to some extent in NAFLD development [17–19].
Remarkably high levels of leptin were observed in the
synthetic diet with LPS group as compared to other groups
(p<0.01) (Table 2).
Plasma LPS concentrations did not show a significant
difference among all groups (data not shown).
Histological analysis
Several fatty droplets and focal necrosis were observed in
the synthetic diet with LPS group (Fig. 2). This finding
coincided with biochemical examinations of blood and liver.
Moreover, the livers of rats in the synthetic diet with LPS
group showed mild pericellular fibrosis (Fig. 3).
Hepatic mRNA expressions in rats
Observed histological findings suggested expressions of
cytokines involved in inflammation and fibrosis. TGF-β1
produced from Kupffer cells and infiltrating inflammatory
cells activates hepatic stellate cells (HSCs) that play a role in
fibrogenesis in the liver, and result in accumulation of type 1
collagen [20–22]. Since TGF-β1,  α-SMA; a marker of
activated HSCs, and type 1 collagen are associated with
hepatic fibrosis, their mRNA expressions were examined
and found to be relatively higher in the synthetic diet with
LPS group (Figs. 4–6) [23].
Discussion
To evaluate the current role of LPS in NASH development
using the two-hit theory, we employed Zucker (fa/fa) rats
who developed obesity and type 2 diabetes. We found that
12 weeks of exposure to a synthetic diet and subsequent 2-
week treatment with low-dose LPS led to steatosis and
focal necrosis accompanied by fibrosis in the livers of
Fig. 2. Effects of a synthetic diet and LPS treatment on the livers of Zucker (fa/fa) rats. Various fatty droplets and focal necrosis are ob-
served in the liver of synthetic diet-fed Zucker (fa/fa) rats treated with LPS. H&E staining (original magnification, 200×).
Fig. 3. Effects of a synthetic diet and LPS treatment on the livers of Zucker (fa/fa) rats. Mild fibrosis is observed in the liver of synthet-
ic diet-fed Zucker (fa/fa) rats treated with LPS. Azan staining (original magnification, 200×).S. Fukunishi et al.
J. Clin. Biochem. Nutr.
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Zucker (fa/fa) rats as confirmed by histological findings.
Elevation of plasma ALT levels and increase in accumula-
tion of hepatic TG supported the development of steatosis
with liver damage. We showed that subsequent 2-week
treatment with LPS stimulated expressions of profibrogenic
mRNAs such as TGF-β1, α-SMA, and type 1 collagen α1 in
the livers of synthetic diet-fed rats. The increase in these
hepatic mRNA expressions corresponded to the histological
findings in the livers of synthetic diet-fed rats treated with
LPS.
Zucker (fa/fa) rats are highly susceptible to low-dose
LPS for short term and develop steatohepatitis, but fibrosis
development in those rats was not confirmed [8]. The
combination of 12-week exposure to a synthetic diet and
subsequent 2-week treatment with LPS induced hepatic
steatosis and fibrosis. Hepatic fibrosis was not induced in
regular diet-fed rats, and was therefore induced by the com-
bination of exposure to a synthetic diet and LPS treatment.
Another interesting result was that the synthetic diet-fed
Zucker (fa/fa) rats treated with LPS showed an increase in
body weight and elevation of liver/body weight ratio.
This may be because the subsequent 2-week treatment with
LPS synergistically enhanced accumulation of hepatic TG
into the hepatocytes of synthetic diet-fed rats, which
corresponded with the histological findings. It has also been
suggested that induction of insulin resistance due to LPS
treatment can promote adipose accumulation in rats [24].
The histological findings and biochemical examinations
in the present study may highlight a relationship between
LPS treatment and plasma leptin levels on the development
of hepatic fibrosis. We confirmed that LPS treatment
induced a significant increase in plasma leptin levels in
synthetic diet-fed Zucker (fa/fa) rats, which was indepen-
dent of liver damage, hyperglycemia, and hyperinsulinemia
through TNF-α mediated by LPS [25]. Leptin is produced
Fig. 4. Expression of TGF-β1 mRNA in the liver of synthetic
diet-fed Zucker (fa/fa) rats treated with LPS. TGF-β1
mRNA expressions are significantly increased in rat
livers as evaluated by quantitative RT-PCR. Data are
mean ± SD (*,**: p<0.01).
Fig. 5. Expression of α-SMA mRNA in the liver of synthetic
diet-fed Zucker (fa/fa) rats treated with LPS. α-SMA
mRNA expressions are significantly increased in rat
livers as evaluated by quantitative RT-PCR. Data are
mean ± SD (*,**: p<0.01).
Fig. 6. Expression of type 1 collagen α1 mRNA in the liver of
synthetic diet-fed Zucker (fa/fa) rats treated with LPS.
Type 1 collagen α1 mRNA expressions are significantly
increased in rat livers as evaluated by quantitative RT-
PCR. Data are mean ± SD (*,**: p<0.01).The Role of LPS on NASH
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from adipocytes [17]. It activates HSCs and contributes to
the development of hepatic fibrosis to some extent without
leptin signaling [18, 19]. Increase in plasma leptin levels in
synthetic diet-fed rats observed in the present study may be
induced by treatment with LPS itself. This relationship led
us to the hypothesis that LPS may be a risk factor for hepatic
fibrosis.
Hepatic steatosis in humans gradually progresses with
daily consumption of food. Excessive intake of disaccharides
induces accumulation of triglycerides in hepatocytes.
Zucker (fa/fa) rats develop hepatic steatosis by short-term
feeding of a diet containing a high content of disaccharides
such as sucrose (85.7 cal% to carbohydrate) [16]. We con-
firmed that our diet containing a low content of disaccharides
such as sucrose and lactose (17.4 cal% to carbohydrate)
compared with the diet induced gradual hepatic steatosis in
Zucker (fa/fa) rats. Therefore, it was important that hepatic
steatosis in Zucker (fa/fa) rats was gradually induced by 12-
week feeding of the diet used in the present study because it
was the “first hit” of the two-hit theory.
NASH is commonly observed in patients with obesity and
in type 2 diabetes [1]. Zucker (fa/fa) rats lack leptin signals.
Although the deficiency is rarely observed in obese patients,
these rats reflect metabolic abnormalities in humans [26].
We think that the combination of Zucker (fa/fa) rats and LPS
contained in normal portal blood is significant. Compared
with the result by treatment with probiotics, our results
suggested that LPS treatment was associated with the
development of hepatic fibrosis [12,  13]. Histological
findings in the livers of synthetic diet-fed Zucker (fa/fa) rats
treated with LPS did not demonstrate typical steatohepatitis,
but this result suggested that LPS had a role in the patho-
genesis of hepatic fibrosis in the two-hit theory as the
“second hit.” We suggest that our protocol may be useful for
studying the role of LPS during the development of hepatic
fibrosis in the two-hit theory.
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